Related references
Note: Only part of the references are listed.A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantation
Borje S. Andersson et al.
BONE MARROW TRANSPLANTATION (2022)
Changing Landscape in the Treatment of Adult Acute Lymphoblastic Leukemia (ALL)
Tina Kuenz et al.
CANCERS (2022)
Clofarabine treatment of KMT2Ar infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16
Tanja A. Gruber et al.
BLOOD ADVANCES (2022)
Progress against childhood and adolescent acute lymphoblastic leukaemia in the Netherlands, 1990-2015
Ardine M. J. Reedijk et al.
LEUKEMIA (2021)
Effectiveness and Safety of Clofarabine Monotherapy or Combination Treatment in Relapsed/Refractory Childhood Acute Lymphoblastic Leukemia: A Pragmatic, Non-interventional Study in Korea
Jung Yoon Choi et al.
CANCER RESEARCH AND TREATMENT (2021)
Clofarabine Commandeers the RNR-α-ZRANB3 Nuclear Signaling Axis
Marcus J. C. Long et al.
CELL CHEMICAL BIOLOGY (2020)
Refractory acute lymphoblastic leukemia in Chinese children: bridging to stem cell transplantation with clofarabine, cyclophosphamide and etoposide
Anthony P. Y. Liu et al.
ANNALS OF HEMATOLOGY (2016)
Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan
Katsuyoshi Koh et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi-center study
A. Lu et al.
BLOOD CANCER JOURNAL (2016)
Recent advances and novel treatment paradigms in acute lymphocytic leukemia
Nikolaos Papadantonakis et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2016)
The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia
Dominique J. P. M. Stumpel et al.
EUROPEAN JOURNAL OF CANCER (2015)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial
Stefan Faderl et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
French real life experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia
Pascale Trioche et al.
EXPERIMENTAL HEMATOLGY & ONCOLOGY (2012)
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
Nobuko Hijiya et al.
BLOOD (2011)
Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia
David O'Connor et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Mechanisms of anti-cancer action and pharmacology of clofarabine
Anna Zhenchuk et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Outcome of Adults With Acute Lymphocytic Leukemia After Second Salvage Therapy
Susan O'Brien et al.
CANCER (2008)
A European phase II study (BIOV-111) of clofarabine (Evoltra®) in refractory and relapsed childhood acute lymphoblastic leukemia:: Final results
Pamela Kearns et al.
BLOOD (2007)
Leukaemia incidence and survival in children and adolescents in Europe during 1978-1997. Report from the Automated Childhood Cancer Information System project
J. W. W. Coebergh et al.
EUROPEAN JOURNAL OF CANCER (2006)
Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group
Joanne M. Hilden et al.
BLOOD (2006)
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
S Jeha et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia
S Jeha et al.
BLOOD (2004)
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia
H Kantarjian et al.
BLOOD (2003)
Share Paper
